Press Releases - 2024-10-09
Celea Therapeutics – Deupirfenidone (LYT-100)
PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting
Press Releases - 2024-09-06
PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies
Press Releases - 2024-08-22
PureTech Appoints Michele Holcomb, PhD, to Board of Directors